[1] |
中华医学会皮肤性病学分会免疫学组, 特应性皮炎协作研究中心. 中国特应性皮炎诊疗指南(2020版)[J]. 中华皮肤科杂志, 2020,53(2):81⁃88. doi: 10.35541/cjd.20191000.
|
[2] |
中华医学会皮肤性病学分会儿童皮肤病学组. 中国儿童特应性皮炎诊疗共识(2017版)[J]. 中华皮肤科杂志, 2017,50(11):784⁃789. doi: 10.3760/cma.j.issn.0412⁃4030.2017.11.002.
|
[3] |
Wollenberg A, Kinberger M, Arents B, et al. European guideline (EuroGuiDerm) on atopic eczema ⁃ part II: non⁃systemic treatments and treatment recommendations for special AE patient populations[J]. J Eur Acad Dermatol Venereol, 2022,36(11):1904⁃1926. doi: 10.1111/jdv.18429.
|
[4] |
中华医学会皮肤性病学分会儿童学组, 中国医师协会皮肤科医师分会儿童皮肤病专业委员会. 功效性护肤品在儿童特应性皮炎中的应用指南[J]. 中国皮肤性病学杂志, 2020,34(9):977⁃981. doi: 10.13735/j.cjdv.1001⁃7089.202006019.
|
[5] |
Eichenfield LF, Tom WL, Chamlin SL, et al. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis[J]. J Am Acad Dermatol, 2014,70(2):338⁃351. doi: 10.1016/j.jaad.2013.10.010.
|
[6] |
Hanifin JM, Thurston M, Omoto M, et al. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group[J]. Exp Dermatol, 2001,10(1):11⁃18. doi: 10.1034/j.1600⁃0625.2001.100102.x.
|
[7] |
Wollenberg A, Barbarot S, Bieber T, et al. Consensus⁃based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I[J]. J Eur Acad Dermatol Venereol, 2018,32(5):657⁃682. doi: 10.1111/jdv.14891.
|
[8] |
李嘉文, 刘达, 刘党生, 等. 乳酸菌胞外多糖产生菌的筛选与初步研究[J]. 中国微生态学杂志, 2019,31(9):1027⁃1033. doi: 10.13381/j.cnki.cjm.201909007.
|
[9] |
Ma L, Li P, Tang J, et al. Prolonging time to flare in pediatric atopic dermatitis: a randomized, investigator⁃blinded, controlled, multicenter clinical study of a ceramide⁃containing moisturizer[J]. Adv Ther, 2017,34(12):2601⁃2611. doi: 10.1007/s12325⁃017⁃0640⁃6.
|
[10] |
Wang S, Wang L, Li P, et al. The improvement of infantile atopic dermatitis during the maintenance period: a multicenter, randomized, parallel controlled clinical study of emollients in Prinsepia utilis Royle[J]. Dermatol Ther, 2020,33(2):e13153. doi: 10.1111/dth.13153.
|
[11] |
中国医师协会皮肤科医师分会过敏性疾病专业委员会, 中华医学会皮肤性病学分会特应性皮炎研究中心, 中国医疗保健国际交流促进会皮肤科分会. 特应性皮炎瘙痒管理专家共识[J]. 中华皮肤科杂志, 2021,54(5):391⁃396. doi: 10.35541/cjd. 20210056.
|
[12] |
中国中西医结合学会皮肤性病专业委员会环境与职业性皮肤病学组, 中华医学会皮肤性病学分会儿童学组, 中国老年保健医学研究会皮肤科分会. 特应性皮炎外用制剂合理应用及患者指导专家共识[J]. 中华皮肤科杂志, 2022,55(4):281⁃288. doi: 10.35541/cjd.20210833.
|
[13] |
Liu L, Ong G. A randomized, open⁃label study to evaluate an intermittent dosing regimen of fluticasone propionate 0.05% cream in combination with regular emollient skin care in reducing the risk of relapse in pediatric patients with stabilized atopic dermatitis[J]. J Dermatolog Treat, 2018,29(5):501⁃509. doi: 10.1080/09546634.2017.1401211.
|
[14] |
Faergemann J, Christensen O, Sjövall P, et al. An open study of efficacy and safety of long⁃term treatment with mometasone furoate fatty cream in the treatment of adult patients with atopic dermatitis[J]. J Eur Acad Dermatol Venereol, 2000,14(5):393⁃396. doi: 10.1046/j.1468⁃3083.2000.00099.x.
|
[15] |
Li AW, Yin ES, Antaya RJ. Topical corticosteroid phobia in atopic dermatitis: a systematic review[J]. JAMA Dermatol, 2017,153(10):1036⁃1042. doi: 10.1001/jamadermatol.2017.2437.
|
[16] |
Li Y, Han T, Li W, et al. Awareness of and phobias about topical corticosteroids in parents of infants with eczema in Hangzhou, China[J]. Pediatr Dermatol, 2018,35(4):463⁃467. doi: 10.1111/pde.13527.
|